Anna Berry, MD (she/her/hers)

SVP Molecular Medicine and Customer Insights
Syapse

Anna Berry, MD is Senior Vice President of Molecular Medicine and Customer Insights at Syapse, a leading Precision Oncology Real World Data company, where she leverages her medical and scientific expertise to deliver innovative solutions for cancer care. Dr. Berry has over 25 years of experience as a molecular pathologist, including 9 years spent launching the Molecular Pahtology Clinical Laboratory and Molecular Genetic Pathology Fellowship at UCSF, and 7 years spent launching a comprehensive Precision Oncology Program at the Swedish Cancer Institue in Seattle. Currently, Dr. Berry leads the development and implementation of biomarker data strategies and partnerships, enabling the integration and analysis of genomic, molecular, and clinical data from diverse sources. Additionally, she oversees the Customer Insights team, which designs and conducts sophisticated and collaborative research studies and programs using real world clinical and laboratory data. Her passion is empowering physicians, researchers, and patients with actionable insights and evidence-based guidance, to advance the field of tumor genomics and molecular oncology

Poster(s):

• (I014) Normalization of Real-World Sequence Variant Data from Heterogeneous Sources
  Friday, November 17, 2023

  9:15 AM - 10:15 AM MST